These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9029054)

  • 1. Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats.
    Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Fagerness PE
    Drug Metab Dispos; 1997 Feb; 25(2):228-42. PubMed ID: 9029054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
    Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Zhang W; Branstetter DG
    Drug Metab Dispos; 1997 Jul; 25(7):828-39. PubMed ID: 9224777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
    Chang M; Sood VK; Kloosterman DA; Hauer MJ; Fagerness PE; Sanders PE; Vrbanac JJ
    Drug Metab Dispos; 1997 Jul; 25(7):814-27. PubMed ID: 9224776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism, and excretion of atevirdine in the rat.
    Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Schuette MR; Judy RW; Voorman RL; Maio SM; Slatter JG
    Drug Metab Dispos; 1998 Oct; 26(10):1008-18. PubMed ID: 9763407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate.
    Borin MT; Chambers JH; Carel BJ; Gagnon S; Freimuth WW
    Clin Pharmacol Ther; 1997 May; 61(5):544-53. PubMed ID: 9164416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test.
    Cheng CL; Smith DE; Carver PL; Cox SR; Watkins PB; Blake DS; Kauffman CA; Meyer KM; Amidon GL; Stetson PL
    Clin Pharmacol Ther; 1997 May; 61(5):531-43. PubMed ID: 9164415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A.
    Voorman RL; Maio SM; Hauer MJ; Sanders PE; Payne NA; Ackland MJ
    Drug Metab Dispos; 1998 Jul; 26(7):631-9. PubMed ID: 9660845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
    Balani SK; Goldman ME; Kauffman LR; Varga SL; O'Brien JA; Smith SJ; Olah TV; Ramjit HG; Schorn TW; Pitzenberger SM
    Drug Metab Dispos; 1993; 21(4):598-604. PubMed ID: 7690697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delavirdine levels in women.
    Vazquez E
    Posit Aware; 1997; 8(4):14. PubMed ID: 11364481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The disposition and metabolism of GW695634: a non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS.
    de Serres M; Moss L; Sigafoos J; Sefler A; Castellino S; Bowers G; Serabjit-Singh C
    Xenobiotica; 2010 Jun; 40(6):437-45. PubMed ID: 20380622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients.
    Borin MT; Chambers JH; Carel BJ; Freimuth WW; Aksentijevich S; Piergies AA
    Antiviral Res; 1997 Jun; 35(1):53-63. PubMed ID: 9224961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.
    Voorman RL; Maio SM; Payne NA; Zhao Z; Koeplinger KA; Wang X
    J Pharmacol Exp Ther; 1998 Oct; 287(1):381-8. PubMed ID: 9765359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.
    Johnson KA; Prakash C
    Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
    Balani SK; Kauffman LR; Arison BH; Olah TV; Goldman ME; Varga SL; O'Brien JA; Ramjit HG; Rooney CS; Hoffman JM
    Drug Metab Dispos; 1994; 22(2):200-5. PubMed ID: 7516852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.